Evidence mapPaperPMID 41208706Full record

ArticleCirculation2026

miR-499 in Platelet-Derived Extracellular Vesicles Augments Inflammatory Cell Generation and Cardiac Remodeling After Myocardial Infarction.

Lee Ohayon-Steckel, Xinyi Zhang, Shagufta Haque, Mohammad A Uddin, Ankush Dasari, Dylan G Kurian, Emilie Coppin, Niranjana Natarajan, Ebin Johny, Aarush Dutta and 7 more

Abstract read
In one paragraph

Article in Circulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Targeting Arterial Dysfunction in Cardiovascular Disease Using Stem Cell-Based Therapies.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Lee Ohayon-Steckel *Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute (L.O.-S., S.H., M.A.U., A.D., D.G.K., N.N., E.J., A.D., C.E.-D., B.W., P.D.), University of Pittsburgh, PA.ORCID 0000-0002-8228-6529
Xinyi Zhang *Department of Cardiology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China (X.Z.).ORCID 0000-0002-5846-337X
Shagufta Haque *Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute (L.O.-S., S.H., M.A.U., A.D., D.G.K., N.N., E.J., A.D., C.E.-D., B.W., P.D.), University of Pittsburgh, PA.
Mohammad A Uddin *Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute (L.O.-S., S.H., M.A.U., A.D., D.G.K., N.N., E.J., A.D., C.E.-D., B.W., P.D.), University of Pittsburgh, PA.ORCID 0000-0002-5498-2535
Ankush DasariPittsburgh Heart, Lung, Blood, and Vascular Medicine Institute (L.O.-S., S.H., M.A.U., A.D., D.G.K., N.N., E.J., A.D., C.E.-D., B.W., P.D.), University of Pittsburgh, PA.ORCID 0000-0003-3042-5731
Dylan G KurianPittsburgh Heart, Lung, Blood, and Vascular Medicine Institute (L.O.-S., S.H., M.A.U., A.D., D.G.K., N.N., E.J., A.D., C.E.-D., B.W., P.D.), University of Pittsburgh, PA.
Emilie CoppinRegeneration in Hematopoiesis, Institute for Immunology, TU Dresden, Germany (E.C.).ORCID 0000-0001-8987-0050
Niranjana NatarajanPittsburgh Heart, Lung, Blood, and Vascular Medicine Institute (L.O.-S., S.H., M.A.U., A.D., D.G.K., N.N., E.J., A.D., C.E.-D., B.W., P.D.), University of Pittsburgh, PA.
Ebin JohnyPittsburgh Heart, Lung, Blood, and Vascular Medicine Institute (L.O.-S., S.H., M.A.U., A.D., D.G.K., N.N., E.J., A.D., C.E.-D., B.W., P.D.), University of Pittsburgh, PA.ORCID 0000-0002-8857-9357
Aarush DuttaPittsburgh Heart, Lung, Blood, and Vascular Medicine Institute (L.O.-S., S.H., M.A.U., A.D., D.G.K., N.N., E.J., A.D., C.E.-D., B.W., P.D.), University of Pittsburgh, PA.ORCID 0009-0004-4983-4249
Yingshi OuyangDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Research Institute (Y.O., Y.S.), University of Pittsburgh, PA.ORCID 0000-0002-8970-1297
Cristina Espinosa-DiezPittsburgh Heart, Lung, Blood, and Vascular Medicine Institute (L.O.-S., S.H., M.A.U., A.D., D.G.K., N.N., E.J., A.D., C.E.-D., B.W., P.D.), University of Pittsburgh, PA.ORCID 0000-0002-5868-3807
Lotte StiekemaDepartment of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, The Netherlands (L.S., E.S.S.).
Erik S StroesDepartment of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, The Netherlands (L.S., E.S.S.).
Yoel SadovskyDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Research Institute (Y.O., Y.S.), University of Pittsburgh, PA.ORCID 0000-0003-2969-6737
Bing WangPittsburgh Heart, Lung, Blood, and Vascular Medicine Institute (L.O.-S., S.H., M.A.U., A.D., D.G.K., N.N., E.J., A.D., C.E.-D., B.W., P.D.), University of Pittsburgh, PA.ORCID 0000-0002-5185-3500
Partha DuttaPittsburgh Heart, Lung, Blood, and Vascular Medicine Institute (L.O.-S., S.H., M.A.U., A.D., D.G.K., N.N., E.J., A.D., C.E.-D., B.W., P.D.), University of Pittsburgh, PA.ORCID 0000-0001-7456-1757

Funding

Mechanisms of Myocardial Infarction-induced insulin resistanceR01HL143967 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Partha Dutta · 2022 to 2022
$516k
Cardioprotective role of Humanin in agingR01AG069399 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2025 to 2025
$461k
The role of SerpinB2 in insulin resistance and inflammationR01DK129339 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2025 to 2025
$434k
Investigating the Role of Macrophages in Heart Failure with Preserved Ejection FractionR00HL157689 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2025 to 2025
$249k
BLRD VA I01 BX006392NHLBI NIH HHS R00 HL121076NHLBI NIH HHS R00 HL157689NHLBI NIH HHS R01 HL142629NHLBI NIH HHS R01 HL143967NIA NIH HHS R01 AG069399NIDDK NIH HHS R01 DK129339NIH HHS S10 OD019973
6 · The paper itself

Abstract

backgroundEmergency myelopoiesis by bone marrow hematopoietic stem and progenitor cells (HSPCs) exacerbates disease pathology in various chronic diseases, including myocardial infarction (MI) and atherosclerosis. However, the mechanisms triggering myelopoiesis in the bone marrow after a distant organ injury, such as MI, remain unknown.

methodsWe ligated the left descending coronary artery to induce MI in mice. Platelet-derived extracellular vesicles (pEVs) were detected and enumerated in mice and patients with MI using NanoSight, ImageStream, and flow cytometry. microRNA in pEVs was quantified using a microRNA array. We used parabiosis, flow cytometry, adoptive transfer experiments, and transgenic mice to assess the effects of pEVs and microRNA on HSPC lineage commitment and inflammatory cell generation. In addition, we carried out RNA sequencing, luciferase assay, lentivirus-mediated in vivo gene overexpression, and echocardiography to evaluate the merit of lactoferrin/lactotransferrin in post-MI pathogenesis.

resultsIn this study, we demonstrate that patients and mice with MI and mice with hindlimb ischemia exhibit an increased number of circulating pEVs, which, in turn, augment HSPC number and proliferation in the bone marrow, leading to inflammatory myeloid cell generation and disease progression. S100A8/9 (S100 calcium-binding protein A8/A9), an alarmin complex produced by cardiomyocytes after MI, induced pEV secretion. In vivo and in vitro inhibition of platelet activation and exocytosis, and HSPC endocytosis, markedly lessened the production of pEV, HSPC proliferation, and myeloid cell generation in emergency hematopoiesis. A microRNA array revealed that pEVs isolated after MI had elevated cargo levels of miR-499 and miR-184, which were enriched in reticulated platelets after MI. miR-499 and miR-184 overexpression in mouse and human HSPCs resulted in enhanced hematopoiesis and myelopoiesis. miR-499-deficient pEVs were inefficient in stimulating emergency myelopoiesis and inducing cardiac remodeling after MI. RNA sequencing analysis, luciferase assay, and lentivirus-mediated in vivo gene overexpression demonstrated that miR-499 bound to the 3' region of lactoferrin/lactotransferrin in HSPC to downregulate this gene, promoting myelopoiesis and unleashing inflammation.

conclusionsOur study suggests that pEVs generated after MI induce HSPC proliferation and inflammatory cell generation. These discoveries uncover several therapeutic targets to reduce cardiac inflammation and remodeling after MI.

Indexed as

Blood PlateletsExtracellular VesiclesMicroRNAsMyocardial InfarctionVentricular RemodelingAnimalsDisease Models, AnimalFemaleHematopoietic Stem CellsHumansMaleMiceMice, Inbred C57BLMice, TransgenicMyelopoiesisMicroRNAsMIRN499 microRNA, humanhematopoiesisinflammationlactoferrinmicroRNAsmyocardial infarction

Identifiers

PMID41208706
PMCPMC12743312

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.